AI unveils secrets of protein stability

Researchers at the Center for Algorithmic and Robotized Synthesis within the Institute for Basic Science have taken a significant step forward in understanding the stability of proteins by leveraging the power of AI. The research team used AlphaFold2 to explore how mutations affect protein stability-; a crucial factor in ensuring proteins function correctly and do not cause diseases like Alzheimer’s.

AHA 2024: Phase III BROOKLYN trial – safety and efficacy of obicetrapib in HeFH patients – Pharmaceutical Technology

On 18 November, at the American Heart Association (AHA) 2024 Annual Scientific Sessions in Chicago, Illinois, US, during a late-breaking session on the topic of

November 20, 2024

Modeling a sustainable plant-based healthy diet for a dietary transition in the United States

Sustainable dietary modeling and formulation in the animal-to-plant-based dietary (PBD) transition.

November 30, 2023

Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug

Plus, news about Abilita Therapeutics, Orion, Novartis, XGEN Venture, Palleon, Henlius, TigaTx, HERVolution Therapeutics and Krystal Biotech: Gilead now owns 30% of Assembly Biosciences: The

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.